STX — Shield Therapeutics Income Statement
0.000.00%
Last trade - 00:00- £10.56m
- £2.74m
- £5.49m
- 24
- 48
- 13
- 17
Annual income statement for Shield Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | Interim Report |
| Standards: | — | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.9 | 0.719 | 10.4 | 1.52 | 5.49 |
| Cost of Revenue | |||||
| Gross Profit | 11.6 | 0.234 | 9.03 | 0.539 | 2.45 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 17 | 9.75 | 12.5 | 21.8 | 54.9 |
| Operating Profit | -5.16 | -9.04 | -2.15 | -20.3 | -49.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.15 | -9.07 | -1.89 | -19.9 | -49 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.79 | -8.8 | -2.63 | -19.7 | -49.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.79 | -8.8 | -2.63 | -19.7 | -49.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.79 | -8.8 | -2.63 | -19.7 | -49.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.015 | -0.071 | -0.021 | -0.094 | -0.162 |